Cell Wall Synthesis Antibiotics Flashcards
Beta-lactam
- ) Mechanism
- ) Cidal or static?
- ) Adverse effects
- ) Penicillin mimics D-Ala-D-Ala and irreversibly binds to transpeptidase-> inactivates enzyme-> no peptidoglycan cross-linking occurs-> cell lyses
- ) Bactericidal
- ) Non-toxic at grams/days dose. Side effects: Allergic reactions
ex: penicillin G-> acid labile; Beta-lactamase sensitive
Beta-lactam: Amoxicillin
- ) Mechanism and usage
- ) Affected organisms
- ) Adverse effects
- ) Extened spectrum penicillins; Usage: UTIs, sinusitis, otitis, LRI
- ) Acid stable. Greater acivitiy against Gram negative b/c of ability to penetrate outer membrane.
- ) Adverse reactions
Beta-lactam: Oxacillin, cloxacillin, dicloxacillin
- ) Description
- ) Affected organisms
- ) anti-staphylococcal penicillins; Acid stable; Beta-lactamase resistant
- ) Beta-lactamase producing strains of staph; Not suitable for enterocci, anaerobic bacteria, and gram negative rods/cocci
Cephalosporins
- ) Mechanism of action
- ) Affected organism
- ) Adverse effects
1.) Broad spectrum, ↑ resistance to β-lactamase
2.) Good against MRSA especially
1st gen – don’t penetrate CNS
2nd gen- no allergic cross-reactivity w/ penicillin
3rd gen - Ceftazidime + Beta-lactamase inhibitor(avibactam) =Avycaz
4th gen – penetrate CNS
3.) Hypersensitivity reactions- anaphylaxis; nephritis, granulocytopenia and hemolytic anemia; Candida superinfection
Ceftolozane
- ) Usage
- ) class
- ) Tx of gram negative bacteria that have become resistant to other drugs, **Pseudomonas infections; Complicated UTI’s; Complicated intra-abdominal infections
- ) 5th Generation Cephalosporin
* Ceftolozane/tazobactam = Zerabaxa
Monobactams: Azetreonam
- ) Mechanism of action
- ) Affected organisms
- ) Adverse reactions
- ) Resistant to beta-lactamases
- ) Active against Gram negative rods; does not bind transpeptidases of Gram postive or anerobic bacteria
- ) No major toxicities and no cross reactivity w/ penicillin
Carbapenems: Imipenem
- ) Mechanism of action
- ) Affected organism
- ) Adverse effects
- )Broad spectrum; given w/ Cilastatin – inhibitor of renal dehydropeptidase to increase half-life; imipenem is inactivated by dehydropeptisases in renal tubules
- ) Mixed infections-+/-
- ) GI issues, skin rashes, seizures if renal insuff.; cross-sensitivity in pts w/ penicillin allergies
Beta-lactamase inhibitors: Clavulanic acid
- ) Mechanism of action
- ) Cidal/static & affected organisms
- ) Adverse effects
- )Binds to bacterial β-lactamases covalently, inactivates them irreversibly; use w/ beta-lactam antibiotics to extend 1/2 lives
- ) Neither- no Abx activity
- ) N/A
Betalactamase inhibitor: Avibactam
- ) Description
- ) Differentiates this drug from others of its class
- ) Broader spectrum beta-lactamases inhibitor -> works on class A and C enzymes and some D enzymes
- ) The inhibitor does not contain a beta-lactam core
Vancomycin
- ) Mechanism of action
- ) Affected organism
- ) Side effects
- ) Drug binds to D-Ala-D-Ala nascent peptide pentapeptide -> binding interferes w/ transglycosylation & transpeptidation rxn -> weakend peptidoglycan layer makes cell susceptible to lysis
- )Bacteriocidal; Gram positive – good for MRSA
- ) Minor, phlebitis @ injection site, chills, fever, rare ototoxicity and nephrotoxicity
Daptomycin
- ) Mechanism of action
- ) Affected organisms
- ) Bacterial cell membrane pore former -> K+ loss w/o cell rupture + no toxin release
- ) Gram positive skin/soft tissue infections; MRSA
Polymyxins
- ) Mechanism of action
- ) Affected organisms
- ) Lipopeptides that bind outer membrane of Gram neg bacteria -> permeability of both inner and outer membrane (perforations, not pores)
- ) Gram negatives
Fosfomycin
- ) Mechanism of action
- ) Utility
- )Inhibits 1st committed step in cell wall synthesis (blocks NAG-UDP -> NAM-UDP) via binding covalently to active site cysteine of MurA enzyme
- ) Active against Gram +/-; Syngergistic when combined w/ other antibiotics; Uncomplicated UTIs
Bacitracin
- ) Mechanism of action
- ) Utility
- ) Adverse effects
- )Inhibits 2nd step: inhibits lipid phosphatase -> dephosphorylates lipid carrier of peptidoglycan subunit -> can’t flip NAM out
- ) Gram positive
- ) Only used topically b/c nephrotoxic; allergic reactions
D-cycloserine
- ) Mechanism of action
- ) Utility
- ) Adverse effects
- ) Competitively inhibits alanine racemase and D-alanine ligase
- ) Used in combination with other antibiotics to treat TB
- ) 2nd line drugs: Dose related CNS toxicities